Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.
Ferder N, Eby CS, Deych E, Harris JK, Ridker PM, Milligan P, Goldhaber SZ, King CR, Giri T, McLeod HL, Glynn RJ, Gage BF.
J Thromb Haemost. 2009 Oct 30. [Epub ahead of print]PMID: 19874474 [PubMed - as supplied by publisher]Related articles